September 18 Common over-the-counter medication slashes colorectal cancer recurrence in half Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients with PIK3 pathway alterations.
September 17 Weight loss drugs could add years to Americans' lives, researchers project New research reveals that GLP-1 drugs may significantly lower mortality rates in Americans by 2045, as obesity contributes to 70% of leading death causes in high-income countries.
September 12 Common heart drug doubles as off-label anxiety aid, driving surge in prescriptions Psychiatrist Dr. Daniel Amen explains how beta blockers work for anxiety by blocking adrenaline effects, as the medication is growing rapidly in popularity.
September 11 Common prescription drugs linked to surge in fall-related death rates among seniors Certain prescription medications, including beta-blockers and gabapentinoids, could increase fall risk in older adults, as some experts claim that reducing unnecessary drugs could prevent injuries.
September 10 Why microdosing Ozempic could become as common as taking a multivitamin GLP-1 medications like Ozempic show promise for multiple health conditions, as experts explore microdosing benefits for blood sugar control and longevity.
September 9 Trump administration targets big pharma for deceptive drug advertising The Trump administration issued warnings to thousands of pharmaceutical companies to crack down on deceptive advertising.
September 8 Psychedelic drug popular in 1960s could ease anxiety as doctors share warnings A new study shows that LSD reduced anxiety symptoms in adults with generalized anxiety disorder, with 100-microgram doses proving most effective in a clinical trial.
September 8 'Next Ozempic' aims to deliver 30% weight loss with fewer side effects Scientists have created a pre-clinical weight loss drug combining GLP-1, GIP, glucagon and peptide YY hormones to match bariatric surgery effectiveness.
September 4 COVID-19 infection risk cut 'significantly' with simple nasal spray, research finds A phase 2 study shows that azelastine nasal spray lowered coronavirus infection rates to 2.2% compared to 6.7%, researchers at Germany's Saarland University revealed.
September 2 Could GLP-1 weight-loss medications like Ozempic become the 'everything drug'? Medical experts discuss whether GLP-1 medications, including Mounjaro and Zepbound, could become comprehensive treatments for multiple health conditions.